Literature DB >> 9661039

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to BAY 12-8039, trovafloxacin, and ciprofloxacin.

J E Hoppe, A Dalhoff, D Pfründer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661039      PMCID: PMC105701     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.

Authors:  J E Hoppe; C G Simon
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 2.  Tissue penetration of the new quinolones in humans.

Authors:  D N Gerding; J A Hitt
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

3.  Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors:  T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

4.  Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.

Authors:  M E Appleman; T L Hadfield; J K Gaines; R E Winn
Journal:  Diagn Microbiol Infect Dis       Date:  1987-10       Impact factor: 2.803

5.  In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative.

Authors:  M Asahara; A Tsuji; S Goto; K Masuda; A Kiuchi
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

6.  In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

Authors:  A Dalhoff; U Petersen; R Endermann
Journal:  Chemotherapy       Date:  1996 Nov-Dec       Impact factor: 2.544

7.  In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone.

Authors:  B B Gooding; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

8.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem.

Authors:  J E Hoppe; E Rahimi-Galougahi; G Seibert
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

  8 in total
  2 in total

1.  Emergence of quinolone-resistant Bordetella pertussis in Japan.

Authors:  Masayuki Ohtsuka; Ken Kikuchi; Kenichiro Shimizu; Namiko Takahashi; Yuka Ono; Takashi Sasaki; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

Review 2.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.